HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- A global challenge: Treating children with cancer in developing countries
-
- Combination of capecitabine and docetaxel did not reduce recurrence in operable breast cancer
- Gene mutation mapped evolution from myelodysplastic syndrome to AML
- Green tea consumption reduced lung cancer risk
- Increased mammography screening linked to reduced treatment, recurrence in women aged 40 to 49 years
- Low-dose rituximab plus steroids demonstrated safety, efficacy in autoimmune hemolytic anemia
- Minority, lower-income patients more likely to report unmet needs for symptom management
- STAT3 regulated IKBKE in response to nicotine induced via tobacco carcinogen
- Stereotactic body radiotherapy improved initial survival rates for those with COPD
-
- Symposium spotlights progress in esophageal, gastric cancers David H. Ilson, MD, PhD
- Complementary approach to discovery would change rules of the game William Wood, MD
- 5-year survival for pediatric ALL exceeds 90%
- Radioactive iodine ablation not linked to survival benefit in differentiated thyroid cancer
- Rise in bilateral neck disease likely caused by increase in tonsillar cancer
- Studies add to evidence that aspirin may help prevent, treat cancer
- New standards guidelines provide palliative care road map for practices
- Hypertension associated with VEGF inhibitors must be detected, treated Lisa K. Lohr, PharmD, BCPS, BCOP
-